Home › Funds › Maverick Capital › BAX
Maverick Capital position in BAX
BAXTER INTL INC · Health Care
Latest position (Q1 2024)2.12M sh
Reported value held$90.60M
Portfolio Weight1.71%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.95K | $318.00K | New |
| Q3 2022 | 300.56K | $16.19M | New |
| Q2 2023 | 2.77M | $126.07M | New |
| Q3 2023 | 2.22M | $83.77M | Reduce |
| Q4 2023 | 2.18M | $84.13M | Reduce |
| Q1 2024 | 2.12M | $90.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BAX
- BlackRock Inc 81.84M sh · $1.74B · Q2 2026
- Pzena Investment Management 65.30M sh · $1.39B · Q2 2026
- Dodge & Cox 58.39M sh · $1.24B · Q2 2026
- Vanguard Group 62.64M sh · $1.20B · Q4 2025
- Fidelity Management & Research (FMR) 53.91M sh · $1.15B · Q2 2026
- Geode Capital Management 14.12M sh · $300.59M · Q2 2026
- Invesco Ltd 12.36M sh · $263.56M · Q2 2026
- UBS Group AG 9.53M sh · $203.16M · Q2 2026
- Goldman Sachs Group 7.15M sh · $152.45M · Q2 2026
- Morgan Stanley 6.36M sh · $135.59M · Q2 2026
- Bank of America Corp 6.24M sh · $132.99M · Q2 2026
- Charles Schwab Investment Management 6.00M sh · $127.85M · Q2 2026